Comparison of stool microbiota compositions, stool alpha1-antitrypsin and calprotectin concentrations, and diarrhoeal morbidity of Indonesian infants fed breast milk or probiotic/prebiotic-supplemented formula

Journal of Paediatrics and Child Health

Volumn 49, Issue 12, 2013, Pages 1032-1039

  Oswari, Hanifah ^a   Prayitno, Lamtorogung ^a   Dwipoerwantoro, Pramita G ^a   Firmansyah, Agus ^a   Makrides, Maria ^b   Lawley, Blair ^d   Kuhn Sherlock, Barbara ^e   Cleghorn, Geoffrey ^c   Tannock, Gerald W ^d  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e FONTERRA RESEARCH CENTRE   (New Zealand)

Author keywords

1 antitrypsin; Bifidobacterium animalis subsp. lactis; calprotectin; Indonesia; prebiotic; probiotic

Indexed keywords

ALPHA 1 ANTITRYPSIN; CALGRANULIN; PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; ARTIFICIAL MILK; BIFIDOBACTERIUM ANIMALIS; BREAST MILK; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; FECES COMPOSITION; FECES MICROFLORA; FEMALE; HUMAN; INDONESIA; INFANT; INFANT FEEDING; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; CALPROTECTIN; INDONESIA; PREBIOTIC; PROBIOTIC; Α1-ANTITRYPSIN;

ALPHA 1-ANTITRYPSIN; BIFIDOBACTERIUM; BIOLOGICAL MARKERS; BREAST FEEDING; COHORT STUDIES; DIARRHEA; FECES; FEMALE; HUMANS; INDONESIA; INFANT; INFANT FORMULA; INFANT, NEWBORN; INTESTINAL MUCOSA; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MICROBIOTA; MILK, HUMAN; POLYMERASE CHAIN REACTION; PREBIOTICS; PROBIOTICS;

EID: 84890549380     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12307     Document Type: Article

References (33)

1. Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI,. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat. Rev. Microbiol. 2008; 6: 776-788.
2. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA,. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat. Rev. Microbiol. 2008; 6: 121-131.
3. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI,. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
4. Sjogren YM, Tomicic S, Lundberg A, et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin. Exp. Allergy 2009; 39: 1842-1851.
5. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328: 228-231.
6. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-227.
7. Favier CF, Vaughan EE, De Vos WM, Akkermans ADL,. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 2002; 68: 219-226.
8. Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 2011; 108 (Suppl. 1): 4578-4585.
9. Tissier H,. Repartition des microbes dans l'intestin du nourrisson. Ann. Inst. Pasteur (Paris) 1905; 19: 109-123.
10. Braegger C, Chmielewska A, Decsi T, et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J. Pediatr. Gastroenterol. Nutr. 2011; 52: 238-250.
11. Tangsilsat D, Atamasirikul K, Treepongkaruna S, Nathsevee S, Sumritsopak R, Kunakom M,. Faecal alpha-antitrysin in healthy and intestinal-disorder Thai children. J. Med. Assoc. Thai. 2007; 90: 1317-1322.
12. Darani HY, Rahimian G, Nafisi M, Amini SA, Najafi A, Sarafpoor M,. Unsuitability of faecal alpha 1-antitrypsin as a marker for differentiation of microbial and non-microbial diarrhea. Kuwait Med. J. 2005; 37: 91-93.
13. Rougé C, Butel M-J, Piloquet H, et al. Faecal calprotectin excretion in preterm infants during the neonatal period. PLoS ONE 2010; 5: 1-6.
14. Joshi S, Lewis SJ, Creanor S, Ayling RM,. Age-related faecal calprotectin, lactoferin and tumour M2-PK concentrations in healthy volunteers. Ann. Clin. Biochem. 2010; 47: 259-263.
15. Nissen AC, van Gils CE, Menheere PP, et al. Faecal calprotectin in healthy term and preterm infants. J. Pediatr. Gastroenterol. Nutr. 2004; 38: 107-108.
16. Tøn H, Brandsnes DS, Holtlund J, Skuibina E, Schjønsby H, Johne B,. Improved assay for faecal calprotectin. Clin. Chim. Acta 2000; 292: 41-54.
17. Rugtveit J, Fagerhol MK,. Age-dependent variations in faecal calprotectin concentrations in children. J. Pediatr. Gastroenterol. Nutr. 2002; 34: 323-324.
18. Furet JP, Firmesse O, Gourmelon M, et al. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 2009; 68: 351-362.
19. Malinen E, Kassinen A, Rinttila T, Palva A,. Comparison of real-time PCR with SYBR Green 1 or 5′-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003; 149: 269-277.
20. Lay C, Rigottier-Gois L, Holmstrom K, et al. Colonic microbiota signatures across five northern European countries. Appl. Environ. Microbiol. 2005; 71: 4153-4155.
21. Yap GC, Chee KK, Hong PY, et al. Evaluation of stool microbiota signatures in two cohorts of Asian (Singapore and Indonesia) newborns at risk of atopy. BMC Microbiol. 2011; 11: 193.
22. Tannock GW, Lawley B, Munro K, et al. Composition of the stool microbiotas of infants fed goat milk-formula in comparison to cow milk-based formula, or breast milk. Appl. Environ. Microbiol. 2013; 79: 3040-3048.
23. Fallani M, Young D, Scott J, et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J. Pediatr. Gastroenterol. Nutr. 2010; 51: 77-84.
24. Grzeskowiak L, Gronlund M-M, Beckmann C, Salminen S, von Berg A, Isolauri E,. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe 2011; 18: 7-13.
25. Grzeskowiak L, Collado MC, Mangani C, et al. Distinct gut microbiota in southeastern African and northern European infants. J. Pediatr. Gastroenterol. Nutr. 2012; 54: 812-816.
26. Harmsen HJM, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000; 30: 61-67.
27. Hopkins MJ, Macfarlane GT, Furrie E, Fite A, Macfarlane S,. Characterisation of intestinal bacteria in infant stools using real-time PCR and Northern hybridisation analyses. FEMS Microbiol. Ecol. 2005; 54: 77-85.
28. Roy D, Ward P, Champagne G,. Differentiation of bifidobacteria by use of pulsed-field gel electrophoresis and polymerase chain reaction. Int. J. Food Microbiol. 1996; 29: 11-29.
29. Mah KW, Chin VI, Wong WS, et al. Effect of a milk formula containing probiotics on the faecal microbiota of asian infants at risk of atopic diseases. Pediatr. Res. 2007; 62: 674-679.
30. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2008; 122: 788-794.
31. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK,. Analysis of the faecal microflora of human subjects consuming a probiotic containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 2000; 66: 2578-2588.
32. Thompson FM, Catto-Smith AG, Moore D, et al. Epithelial growth of the small intestine in human infants. J. Pediatr. Gastroenterol. Nutr. 1998; 26: 506-512.
33. Kapel N, Campeotto F, Kalach N, Baldassare M, Butel MJ, Dupont C,. Faecal calprotectin in term and preterm neonates. J. Pediatr. Gastroenterol. Nutr. 2010; 51: 542-547.